Stress has been shown to facilitate ethanol withdrawal-induced anxiety. Defining neurobiological mechanisms through which stress has such actions is important given the associated risk of relapse. While CRF has long been implicated in the action of stress, current results show that stress elevates the cytokine TNFa in the rat brain and thereby implicates cytokines in stress effects. In support of this view, prior TNFa microinjection into the central amygdala (CeA) of rats facilitated ethanol withdrawal-induced anxiety-a response that could not be attributed to an increase in plasma corticosterone. To test for a possible interaction between cytokines and CRF, a CRF1-receptor antagonist (SSR125543) administered prior to the repeated administration of TNFa or MCP-1/CCL2 reduced the magnitude of the withdrawal-induced anxiety. This finding provided evidence for cytokine action being dependent upon CRF. Additionally, the sensitizing effect of stress on withdrawal-induced anxiety was reduced by treating the repeated stress exposure prior to ethanol with the MEK inhibitor SL327. Consistent with cytokines having a neuromediator function distinct from a neuroimmune action, TNFa increased firing rate and GABA release from CeA neurons. Thus, an interaction of glial and neuronal function is proposed to contribute to the interaction of stress and chronic ethanol. Interrupting this potential glial-neuronal interaction could provide a novel means by which to alter the development of emotional states induced by stress that predict relapse in the alcoholic.
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Introduction
Stress has long been thought to be a significant factor in the etiology of alcoholism (e.g., Breese et al., 2005a Breese et al., ,b, 2011 Koob, 2009; Pohorecky, 1981 Pohorecky, , 1991 Sinha and Li, 2007) . For example, clinical laboratory studies demonstrate that abstinent alcoholics respond with enhanced craving for alcohol (ethanol) when they are exposed to stress-related or ethanol cue-related images (Fox et al., 2007; Sinha and Li, 2007; Sinha et al., 2009 ). Further, anxiety and stress disorders are considerably over-represented in alcoholics, and self-medication of these and related negative emotional states with ethanol remains a conceptual and experimental focus of both basic and clinical research (e.g., Breese et al., 2005a,b; Brady and Lydiard, 1993; Regier et al., 1990; Zhang et al., 2007) . Acute and persistent vulnerability to stress both during acute withdrawal from alcohol and beyond the acute withdrawal period (i.e., during extended abstinence) may play an important role in perpetuating maladaptive drinking behavior. Results from rodent models of chronic ethanol exposure, particularly cyclic patterns of ethanol exposure and withdrawal, support the idea that progressively worsening profiles of withdrawal-like states arise and may persist over time to render subjects vulnerable to future environmental stressors and challenges (Breese et al., 2005b; Overstreet et al., 2002; Valdez et al., 2002) . A number of neurobiological substrates, including those associated with GABA, serotonin, norepinephrine, and corticotrophin releasing factor (CRF) have been implicated in this vulnerability (e.g., Breese et al., 2005b; Hauger et al., 2006; Koob, 2010; Smith and Aston-Jones, 2008) . CRF, in particular, appears to be integral in acute and persistent vulnerability to stress in alcohol dependence (Huang et al., 2010; Koob, 2010; Lowery and Thiele, 2010) . Recent data also implicate the cytokine/chemokine systems in CNS sensitization (e.g., Kawasaki et al., 2008) and in the etiology of chronic ethanol-related phenotypes (Breese et al., 2008; Qin et al., 2008) . For example, prior administration of LPS or cytokines/chemokines accelerates the development of anxiety-like behavior in animals subsequently exposed to ethanol
